claim: nih activ trial of blood thinners allowed enrollment of critically ill covid-19 patients.
evidence_1: informed by the deliberations of these oversight boards, all the trial sites have paused enrollment of the most critically ill hospitalized patients with covid-19.", "coronavirus patients is halted giving anticoagulants to hospitalized covid-19 patients is routine.", "whether the use of full-dose compared to low-dose blood thinners leads to better outcomes in hospitalized patients with less covid-19 severe disease remains a very important question.", "informed by the deliberations of these oversight boards, all of the trial sites have paused enrollment of the most critically ill hospitalised patients with covid-19.", 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  "the trials are continuing to enroll moderately ill hospitalised covid-19 patients.")